Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae

Citation
Bn. Kim et al., Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae, CHEMOTHERA, 46(5), 2000, pp. 303-308
Citations number
31
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
CHEMOTHERAPY
ISSN journal
00093157 → ACNP
Volume
46
Issue
5
Year of publication
2000
Pages
303 - 308
Database
ISI
SICI code
0009-3157(200009/10)46:5<303:TSOACI>2.0.ZU;2-8
Abstract
Background: Resistance of Streptococcus pneumoniae to penicillin is now wid espread and rapidly increasing all over the world. This has led to the crit ical need for alternative antimicrobial therapy. Methods: To assess the act ivities of antimicrobial combinations, including cefotaxime, ceftriaxone, v ancomycin and meropenem, time-kill studies were conducted against five stra ins of penicillin- and cephalosporin-resistant S. pneumoniae at clinically achievable antimicrobial concentrations in cerebrospinal fluid. Results: Co mbinations of an extended-spectrum cephalosporin with vancomycin were not s ynergistic. Meropenem had a comparable bactericidal activity to those combi nations, and its killing activity was not affected by the addition of cefot axime, ceftriaxone or vancomycin. Conclusions: It is suggested that meropen em could be an effective alternative for the treatment of penicillin- and c ephalosporin-resistant pneumococcal meningitis. However, more clinical data are required before it can be recommended as an effective antimicrobial ag ent for such cases. Copyright (C) 2000 S. Karger AG, Basel.